Patients who take a close look at medical science in search of treatments are often appalled by what they discover. On the one hand, there's academic research, a self-contained and self-absorbed universe of its own where data may be internally consistent (on a good day) and robustly reproducible, yet often has little relevance to real-world clinical conditions.

The government should focus on those things only government can do, such as the transfers to lifetime low earners that Social Security provides, and individuals and markets should do what they do best, which includes ordinary retirement saving for middle and high earners.

Alzheimer's is a disease without a cure; the number of people afflicted continues to rise, and it is time for bureaucrats in Washington to support brain science research in the hope of finding a cure.

The Obama plan offers a host of policy proposals that, in the main, address the symptoms but not the underlying disease that afflicts the health care system.

Barack Obama is determined to resolve our differences by talking to other countries; however, this tactic has been used for years with little results.

In case you missed it, AEI health expert Scott Gottlieb, MD explains the transformation of the pharmaceutical industry in a recently published piece (full text below). Drug discovery has become targeted, averse to bureaucracy, and focused on solving more difficult to cure, serious maladies.

No, the government shouldn’t eliminate tax breaks for private universities.

Problems with procurement, corruption, and intellectual property threaten new and innovative malaria treatments.